ALT 0 3 0 3 B-clinical_variable
or 4 6 4 6 O
AST 7 10 7 10 B-clinical_variable
< 11 12 11 12 O
3 13 14 13 14 B-upper_bound
x 15 16 15 16 I-upper_bound
upper 17 22 17 22 I-upper_bound
limit 23 28 23 28 I-upper_bound
of 29 31 29 31 I-upper_bound
normal 32 38 32 38 I-upper_bound

Abdominal 0 9 39 48 B-treatment
/ 9 10 48 49 I-treatment
pelvic 10 16 49 55 I-treatment
CT 17 19 56 58 I-treatment
scan 20 24 59 63 I-treatment
with 25 29 64 68 O
IV 30 32 69 71 O
contrast 33 41 72 80 O
within 42 48 81 87 O
21 49 51 88 90 B-upper_bound
days 52 56 91 95 I-upper_bound
prior 57 62 96 101 I-upper_bound
to 63 65 102 104 O
study 66 71 105 110 O
entry 72 77 111 116 O

Abdominal 0 9 117 126 O
/ 9 10 126 127 O
pelvic 10 16 127 133 O
MR 17 19 134 136 B-clinical_variable
prior 20 25 137 142 B-treatment
to 26 28 143 145 I-treatment
radiation 29 38 146 155 I-treatment
with 39 43 156 160 O
perfusion 44 53 161 170 O
and 54 57 171 174 O
diffusion- 58 68 175 185 O
weighted 69 77 186 194 O
sequences 78 87 195 204 O
and 88 91 205 208 O
MR 92 94 209 211 O
and 95 98 212 215 O
CT 99 101 216 218 B-clinical_variable
sim 102 105 219 222 O
for 106 109 223 226 O
radiation 110 119 227 236 O
planning 120 128 237 245 O
Pet 129 132 246 249 B-treatment
scan 133 137 250 254 I-treatment
within 138 144 255 261 O
21 145 147 262 264 B-upper_bound
days 148 152 265 269 I-upper_bound
prior 153 158 270 275 I-upper_bound
to 159 161 276 278 O
study 162 167 279 284 O
entry 168 173 285 290 O
, 173 174 290 291 O
Functional 175 185 292 302 O
renal 186 191 303 308 O
study 192 197 309 314 O

Ability 0 7 315 322 O
to 8 10 323 325 O
swallow 11 18 326 333 O
oral 19 23 334 338 B-treatment
medications 24 35 339 350 I-treatment

Absolute 0 8 351 359 B-clinical_variable
neutrophil 9 19 360 370 I-clinical_variable
count 20 25 371 376 I-clinical_variable
( 26 27 377 378 I-clinical_variable
ANC 27 30 378 381 I-clinical_variable
) 30 31 381 382 I-clinical_variable
≥ 32 33 383 384 O
1,500 34 39 385 390 B-lower_bound
cells 40 45 391 396 I-lower_bound
/ 45 46 396 397 I-lower_bound
mm3 46 49 397 400 I-lower_bound

Acute 0 5 401 406 O
bacterial 6 15 407 416 B-chronic_disease
or 16 18 417 419 O
fungal 19 25 420 426 B-chronic_disease
infection 26 35 427 436 I-chronic_disease
requiring 36 45 437 446 O
intravenous 46 57 447 458 B-treatment
antibiotics 58 69 459 470 I-treatment
at 70 72 471 473 O
the 73 76 474 477 O
time 77 81 478 482 O
of 82 84 483 485 O
registration 85 97 486 498 O

Age 0 3 499 502 B-age
≥ 4 5 503 504 O
18 6 8 505 507 B-lower_bound

Alkaline 0 8 508 516 B-clinical_variable
phosphatase 9 20 517 528 I-clinical_variable
< 21 22 529 530 O
3 23 24 531 532 B-upper_bound
x 25 26 533 534 I-upper_bound
upper 27 32 535 540 I-upper_bound
limit 33 38 541 546 I-upper_bound
of 39 41 547 549 I-upper_bound
normal 42 48 550 556 I-upper_bound

Any 0 3 557 560 O
major 4 9 561 566 B-clinical_variable
surgery 10 17 567 574 I-clinical_variable
within 18 24 575 581 O
28 25 27 582 584 B-upper_bound
days 28 32 585 589 I-upper_bound
prior 33 38 590 595 I-upper_bound
to 39 41 596 598 O
study 42 47 599 604 O
entry 48 53 605 610 O

Any 0 3 611 614 O
unresolved 4 14 615 625 O
bowel 15 20 626 631 B-chronic_disease
or 21 23 632 634 O
bile 24 28 635 639 B-chronic_disease
duct 29 33 640 644 I-chronic_disease
obstruction 34 45 645 656 I-chronic_disease

Chest 0 5 657 662 B-treatment
CT 6 8 663 665 I-treatment
scan 9 13 666 670 I-treatment
, 13 14 670 671 O
or 15 17 672 674 O
X 18 19 675 676 B-treatment
- 19 20 676 677 I-treatment
ray 20 23 677 680 I-treatment
within 24 30 681 687 O
21 31 33 688 690 B-upper_bound
days 34 38 691 695 I-upper_bound
prior 39 44 696 701 I-upper_bound
to 45 47 702 704 O
study 48 53 705 710 O
entry 54 59 711 716 O

Chronic 0 7 717 724 B-chronic_disease
obstructive 8 19 725 736 I-chronic_disease
pulmonary 20 29 737 746 I-chronic_disease
disease 30 37 747 754 I-chronic_disease
exacerbation 38 50 755 767 B-treatment
or 51 53 768 770 O
other 54 59 771 776 O
respiratory 60 71 777 788 B-chronic_disease
illness 72 79 789 796 I-chronic_disease
requiring 80 89 797 806 O
hospitalization 90 105 807 822 O
or 106 108 823 825 O
precluding 109 119 826 836 O
study 120 125 837 842 O
therapy 126 133 843 850 B-treatment
within 134 140 851 857 O
30 141 143 858 860 B-upper_bound
days 144 148 861 865 I-upper_bound
before 149 155 866 872 O
registration 156 168 873 885 O

Distant 0 7 886 893 B-cancer
metastatic 8 18 894 904 I-cancer
disease 19 26 905 912 I-cancer
, 26 27 912 913 O
second 28 34 914 920 B-cancer
malignancy 35 45 921 931 I-cancer
or 46 48 932 934 O
peritoneal 49 59 935 945 B-chronic_disease
seeding 60 67 946 953 I-chronic_disease

Fasting 0 7 954 961 B-clinical_variable
blood 8 13 962 967 I-clinical_variable
glucose 14 21 968 975 I-clinical_variable
< 22 23 976 977 O
160 24 27 978 981 B-upper_bound
mg 28 30 982 984 I-upper_bound
/ 30 31 984 985 I-upper_bound
dl 31 33 985 987 I-upper_bound

Hemoglobin 0 10 988 998 B-clinical_variable
≥ 11 12 999 1000 O
8.0 13 16 1001 1004 B-lower_bound
g 17 18 1005 1006 I-lower_bound
/ 18 19 1006 1007 I-lower_bound
dl 19 21 1007 1009 I-lower_bound
( 22 23 1010 1011 O
Note 23 27 1011 1015 O
: 27 28 1015 1016 O
The 29 32 1017 1020 O
use 33 36 1021 1024 O
of 37 39 1025 1027 O
transfusion 40 51 1028 1039 B-treatment
or 52 54 1040 1042 O
other 55 60 1043 1048 O
intervention 61 73 1049 1061 O
to 74 76 1062 1064 O
achieve 77 84 1065 1072 O
Hgb 85 88 1073 1076 B-clinical_variable
≥ 89 90 1077 1078 O
8.0 91 94 1079 1082 O
g 95 96 1083 1084 O
/ 96 97 1084 1085 O
dl 97 99 1085 1087 O
is 100 102 1088 1090 O
acceptable 103 113 1091 1101 O
. 113 114 1101 1102 O
) 114 115 1102 1103 O

History 0 7 1104 1111 O
/ 7 8 1111 1112 O
physical 8 16 1112 1120 O
examination 17 28 1121 1132 O
, 28 29 1132 1133 O
including 30 39 1134 1143 O
collection 40 50 1144 1154 O
of 51 53 1155 1157 O
weight 54 60 1158 1164 O
and 61 64 1165 1168 O
vital 65 70 1169 1174 O
signs 71 76 1175 1180 O
, 76 77 1180 1181 O
within 78 84 1182 1188 O
28 85 87 1189 1191 B-upper_bound
days 88 92 1192 1196 I-upper_bound
prior 93 98 1197 1202 I-upper_bound
to 99 101 1203 1205 O
study 102 107 1206 1211 O
entry 108 113 1212 1217 O

Inability 0 9 1218 1227 O
to 10 12 1228 1230 O
undergo 13 20 1231 1238 O
an 21 23 1239 1241 O
MR 24 26 1242 1244 B-treatment
of 27 29 1245 1247 O
the 30 33 1248 1251 O
abdomen 34 41 1252 1259 O
/ 41 42 1259 1260 O
pelvis 42 48 1260 1266 O

Major 0 5 1267 1272 B-treatment
resection 6 15 1273 1282 I-treatment
of 16 18 1283 1285 I-treatment
the 19 22 1286 1289 I-treatment
stomach 23 30 1290 1297 I-treatment
or 31 33 1298 1300 I-treatment
small 34 39 1301 1306 I-treatment
bowel 40 45 1307 1312 I-treatment
that 46 50 1313 1317 O
could 51 56 1318 1323 O
affect 57 63 1324 1330 O
the 64 67 1331 1334 O
absorption 68 78 1335 1345 O
of 79 81 1346 1348 O
capecitabine 82 94 1349 1361 B-treatment

Negative 0 8 1362 1370 B-pregnancy
serum 9 14 1371 1376 I-pregnancy
pregnancy 15 24 1377 1386 I-pregnancy
test 25 29 1387 1391 O
( 30 31 1392 1393 O
if 31 33 1393 1395 O
applicable 34 44 1396 1406 O
) 44 45 1406 1407 O
within 46 52 1408 1414 O
14 53 55 1415 1417 B-upper_bound
days 56 60 1418 1422 I-upper_bound
prior 61 66 1423 1428 I-upper_bound
to 67 69 1429 1431 O
study 70 75 1432 1437 O
entry 76 81 1438 1443 O

Participation 0 13 1444 1457 O
in 14 16 1458 1460 O
another 17 24 1461 1468 O
clinical 25 33 1469 1477 O
treatment 34 43 1478 1487 B-treatment
trial 44 49 1488 1493 O
while 50 55 1494 1499 O
on 56 58 1500 1502 O
study 59 64 1503 1508 O

Pathologically 0 14 1509 1523 O
confirmed 15 24 1524 1533 O
( 25 26 1534 1535 O
histologic 26 36 1535 1545 O
or 37 39 1546 1548 O
cytologic 40 49 1549 1558 O
) 49 50 1558 1559 O
, 50 51 1559 1560 O
locally 52 59 1561 1568 B-cancer
advanced 60 68 1569 1577 I-cancer
, 68 69 1577 1578 O
adenocarcinoma 70 84 1579 1593 B-cancer
of 85 87 1594 1596 O
the 88 91 1597 1600 O
pancreas 92 100 1601 1609 O
; 100 101 1609 1610 O
patients 102 110 1611 1619 O
must 111 115 1620 1624 O
have 116 120 1625 1629 O
unresectable 121 133 1630 1642 O
disease 134 141 1643 1650 O
based 142 147 1651 1656 O
on 148 150 1657 1659 O
institutional 151 164 1660 1673 O
standardized 165 177 1674 1686 O
criteria 178 186 1687 1695 O
of 187 189 1696 1698 O
unresectability 190 205 1699 1714 O
or 206 208 1715 1717 O
medical 209 216 1718 1725 O
inoperability 217 230 1726 1739 O

Patients 0 8 1740 1748 O
must 9 13 1749 1753 O
have 14 18 1754 1758 O
had 19 22 1759 1762 O
at 23 25 1763 1765 O
least 26 31 1766 1771 O
4 32 33 1772 1773 B-lower_bound
months 34 40 1774 1780 I-lower_bound
of 41 43 1781 1783 O
prior 44 49 1784 1789 B-treatment
systemic 50 58 1790 1798 I-treatment
chemotherapy 59 71 1799 1811 I-treatment

Patients 0 8 1812 1820 O
with 9 13 1821 1825 O
and 14 17 1826 1829 O
without 18 25 1830 1837 O
regional 26 34 1838 1846 O
adenopathy 35 45 1847 1857 B-chronic_disease
are 46 49 1858 1861 O
eligible 50 58 1862 1870 O

Platelets 0 9 1871 1880 B-clinical_variable
≥ 10 11 1881 1882 O
100,000 12 19 1883 1890 B-lower_bound
cells 20 25 1891 1896 I-lower_bound
/ 25 26 1896 1897 I-lower_bound
mm3 26 29 1897 1900 I-lower_bound

Pregnancy 0 9 1901 1910 B-pregnancy
or 10 12 1911 1913 O
women 13 18 1914 1919 B-gender
of 19 21 1920 1922 O
childbearing 22 34 1923 1935 O
potential 35 44 1936 1945 O
and 45 48 1946 1949 O
men 49 52 1950 1953 O
who 53 56 1954 1957 O
are 57 60 1958 1961 O
sexually 61 69 1962 1970 O
active 70 76 1971 1977 O
and 77 80 1978 1981 O
not 81 84 1982 1985 B-contraception_consent
willing 85 92 1986 1993 I-contraception_consent
/ 92 93 1993 1994 I-contraception_consent
able 93 97 1994 1998 I-contraception_consent
to 98 100 1999 2001 I-contraception_consent
use 101 104 2002 2005 I-contraception_consent
medically 105 114 2006 2015 I-contraception_consent
acceptable 115 125 2016 2026 I-contraception_consent
forms 126 131 2027 2032 I-contraception_consent
of 132 134 2033 2035 I-contraception_consent
contraception 135 148 2036 2049 I-contraception_consent
during 149 155 2050 2056 O
the 156 159 2057 2060 O
course 160 166 2061 2067 O
of 167 169 2068 2070 O
the 170 173 2071 2074 O
study 174 179 2075 2080 O
and 180 183 2081 2084 O
for 184 187 2085 2088 O
women 188 193 2089 2094 O
, 193 194 2094 2095 O
for 195 198 2096 2099 O
3 199 200 2100 2101 B-upper_bound
months 201 207 2102 2108 I-upper_bound
after 208 213 2109 2114 I-upper_bound
the 214 217 2115 2118 O
last 218 222 2119 2123 O
study 223 228 2124 2129 B-treatment
drug 229 233 2130 2134 I-treatment
administration 234 248 2135 2149 O

Prior 0 5 2150 2155 O
allergic 6 14 2156 2164 O
reaction 15 23 2165 2173 O
to 24 26 2174 2176 O
capecitabine 27 39 2177 2189 B-allergy_name
or 40 42 2190 2192 O
gemcitabine 43 54 2193 2204 B-allergy_name

Prior 0 5 2205 2210 B-treatment
radiotherapy 6 18 2211 2223 I-treatment
to 19 21 2224 2226 O
the 22 25 2227 2230 O
region 26 32 2231 2237 O
of 33 35 2238 2240 O
the 36 39 2241 2244 O
study 40 45 2245 2250 O
cancer 46 52 2251 2257 B-cancer
that 53 57 2258 2262 O
would 58 63 2263 2268 O
result 64 70 2269 2275 O
in 71 73 2276 2278 O
overlap 74 81 2279 2286 O
of 82 84 2287 2289 O
radiation 85 94 2290 2299 B-treatment
therapy 95 102 2300 2307 I-treatment
fields 103 109 2308 2314 O

Serum 0 5 2315 2320 B-clinical_variable
creatinine 6 16 2321 2331 I-clinical_variable
≤ 17 18 2332 2333 O
1.5 19 22 2334 2337 B-upper_bound
mg 23 25 2338 2340 I-upper_bound
/ 25 26 2340 2341 I-upper_bound
dl 26 28 2341 2343 I-upper_bound

Total 0 5 2344 2349 B-clinical_variable
bilirubin 6 15 2350 2359 I-clinical_variable
< 16 17 2360 2361 O
3.0 18 21 2362 2365 B-upper_bound
mg 22 24 2366 2368 I-upper_bound
/ 24 25 2368 2369 I-upper_bound
dL 25 27 2369 2371 I-upper_bound

Transmural 0 10 2372 2382 B-chronic_disease
myocardial 11 21 2383 2393 I-chronic_disease
infarction 22 32 2394 2404 I-chronic_disease
within 33 39 2405 2411 O
3 40 41 2412 2413 B-upper_bound
months 42 48 2414 2420 I-upper_bound
prior 49 54 2421 2426 I-upper_bound
to 55 57 2427 2429 O
study 58 63 2430 2435 O
entry 64 69 2436 2441 O

Uncontrolled 0 12 2442 2454 O
malabsorption 13 26 2455 2468 B-chronic_disease
syndrome 27 35 2469 2477 I-chronic_disease
significantly 36 49 2478 2491 O
affecting 50 59 2492 2501 O
gastrointestinal 60 76 2502 2518 O
function 77 85 2519 2527 O

Unstable 0 8 2528 2536 B-chronic_disease
angina 9 15 2537 2543 I-chronic_disease
and/or 16 22 2544 2550 O
congestive 23 33 2551 2561 B-chronic_disease
heart 34 39 2562 2567 I-chronic_disease
failure 40 47 2568 2575 I-chronic_disease
requiring 48 57 2576 2585 O
hospitalization 58 73 2586 2601 O
within 74 80 2602 2608 O
the 81 84 2609 2612 O
last 85 89 2613 2617 B-upper_bound
6 90 91 2618 2619 I-upper_bound
months 92 98 2620 2626 I-upper_bound

Women 0 5 2627 2632 B-gender
of 6 8 2633 2635 O
childbearing 9 21 2636 2648 O
potential 22 31 2649 2658 O
and 32 35 2659 2662 O
male 36 40 2663 2667 B-gender
participants 41 53 2668 2680 I-gender
who 54 57 2681 2684 O
are 58 61 2685 2688 O
sexually 62 70 2689 2697 O
active 71 77 2698 2704 O
must 78 82 2705 2709 O
practice 83 91 2710 2718 O
adequate 92 100 2719 2727 O
contraception 101 114 2728 2741 O

Zubrod 0 6 2742 2748 B-clinical_variable
performance 7 18 2749 2760 I-clinical_variable
status 19 25 2761 2767 I-clinical_variable
0 26 27 2768 2769 B-lower_bound
- 27 28 2769 2770 O
1 28 29 2770 2771 B-upper_bound
within 30 36 2772 2778 O
1 37 38 2779 2780 B-upper_bound
week 39 43 2781 2785 I-upper_bound
of 44 46 2786 2788 O
study 47 52 2789 2794 O
entry 53 58 2795 2800 O

